Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 48 Official Publication of Indian Association of Medical Microbiologists 
 ~   Next article
 ~   Previous article
 ~   Table of Contents

 ~   Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~   Citation Manager
 ~   Access Statistics
 ~   Reader Comments
 ~   Email Alert *
 ~   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2587    
    Printed174    
    Emailed3    
    PDF Downloaded285    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 REVIEW ARTICLE
Year : 2011  |  Volume : 29  |  Issue : 4  |  Page : 353-358

Transfusion-transmitted hepatitis E: Is screening warranted?


1 Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, Sector D1, Vasant Kunj, New Delhi 110 070, India
2 Department of Virology, Institute of Liver and Biliary Sciences, Sector D1, Vasant Kunj, New Delhi 110 070, India

Correspondence Address:
E Gupta
Department of Virology, Institute of Liver and Biliary Sciences, Sector D1, Vasant Kunj, New Delhi 110 070
India
Login to access the Email id


DOI: 10.4103/0255-0857.90158

PMID: 22120793

Get Permissions

Hepatitis E virus (HEV) is an emerging infectious threat to blood safety. In recent years, there have been a number of publications delineating this threat by providing evidence of the transmissibility of this virus through transfusions. The extent of transmission and its clinical relevance are issues under debate at present. HEV usually causes a self-limiting illness which subsides in a few weeks barring a few cases where fulminant hepatic failure occurs. The virus poses a risk of higher morbidity and mortality in pregnant females, patients with pre-existing liver disease and solid organ transplant recipients. As these categories of patient often require repeated transfusions or massive transfusions, they are exposed to a greater risk of transmission of HEV. At present, there is little evidence to advocate universal screening for this virus but considering that there is no definitive treatment for HEV induced hepatitis, selective screening should be advocated in blood products for high risk recipients in endemic areas.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

2004 - Indian Journal of Medical Microbiology
Published by Medknow

Online since April 2001, new site since 1st August '04